The burgeoning popularity of semaglutide , initially for blood sugar control , is creating significant buzz within the British Isles, prompting a notable shift in hormone trends. Availability these medications remains a complex landscape, with National Health Service coverage currently limited and specialist practices offering treatment at a substa